Clinical Trial News and Research

RSS

Save billions or stick with Humira? Drug brokers steer Americans to the costly choice

Tennessee last year spent $48 million on a single drug, Humira — about $62,000 for each of the 775 patients who were covered by its employee health insurance program and receiving the treatment.

19 Sep 2023

Does a high-dose influenza vaccine reduce cardiovascular disease risk?

Whether a high-dose influenza vaccine is associated with a benefit in reducing CP events.

19 Sep 2023

First real-world observational study of the JADA®System, a medical device to control postpartum hemorrhage (PPH), published in ACOG’s Obstetrics & Gynecology

Organon today announced that Obstetrics & Gynecology, the peer-reviewed journal of the American College of Obstetrics and Gynecology (ACOG), published the results of the RUBY study which reached its primary effectiveness outcome of successfully treating abnormal postpartum uterine bleeding and postpartum hemorrhage with the JADA® System.

19 Sep 2023

New treatment approach effectively treats the most aggressive forms of prostate cancer

Researchers at the University of Chicago Medicine Comprehensive Cancer Center established "proof-of-concept" for a new treatment approach that was able to effectively treat the most aggressive forms of prostate cancer. The treatment showed complete tumor control and long-lasting survival without side effects in a mouse model of advanced prostate cancer.

19 Sep 2023

AR headset proven effective digital tool for improving posture in people with Parkinson’s disease

An augmented-reality headset is an effective digital tool for improving posture and gait in people with Parkinson's disease, according to a recent Cleveland Clinic trial. Findings were published in Neurorehabilitation and Neural Repair.

19 Sep 2023

Nanoparticle gene delivery system shows promise for treating ARDS

Discovery from the lab of Youyang Zhao, PhD, from Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago offers promising treatment approaches for acute respiratory distress syndrome (ARDS) in the elderly that can be caused by severe COVID-19, pneumonia, flu or sepsis. Currently there are no pharmacological or cell-based treatments for ARDS.

19 Sep 2023

New study debunks the myth that almonds are bad for weight loss

When it comes to weight loss, nuts can get a bad rap – while they're high in protein, they're also high in fats, and this often deters those looking to shed a few kilos. But new research from the University of South Australia shows that you can eat almonds and lose weight too.

19 Sep 2023

Stem cell therapy shows promise in treating COVID-19 complications

The use of cell therapy to treat COVID-19 patients can reduce the risk of death from the disease by 60%, according to a systematic review and meta-analysis conducted by researchers at the University of São Paulo (USP) in Brazil, in partnership with colleagues in Germany and the United States.

19 Sep 2023

Adaptive platform trial shows promise for finding new glioblastoma therapies

An innovative phase 2 clinical trial led by Dana-Farber Cancer Institute in collaboration with 10 major brain tumor centers around the country and designed to find new potential treatments for glioblastoma has reported initial results in the Journal of Clinical Oncology. While none of the three therapeutics tested so far improved overall survival of patients, this adaptive platform trial, the first of its kind in neuro-oncology, has the potential to rapidly and efficiently identify therapies that benefit patients.

19 Sep 2023

New study suggests higher buprenorphine doses could help save lives

Individuals with opioid use disorder who were prescribed a lower buprenorphine dose were 20% more likely to discontinue treatment than those on a higher dose, according to a study of patients prescribed buprenorphine in Rhode Island from 2016 to 2020, as fentanyl became widely available.

19 Sep 2023

Cancer drug could play a role in limiting the damaging effects of lung disease in COVID-19 patients

A cancer drug could play an important role in limiting the damaging effects of lung disease in COVID-19 patients, thanks to new research at Hudson Institute of Medical Research.

19 Sep 2023

Health workers warn loosening mask advice in hospitals would harm patients and providers

Nurses, researchers, and workplace safety officers worry new guidelines from the Centers for Disease Control and Prevention might reduce protection against the coronavirus and other airborne pathogens in hospitals.

18 Sep 2023

Low socioeconomic status can negatively impact children's health starting in preschool, study finds

Low socioeconomic status can negatively impact children's health in preschool, along with their ability to follow specialized health education intervention programs, Mount Sinai researchers found in an international study focused on health promotion in schools, including those in the Harlem section of New York City.

18 Sep 2023

Clinical Trial News and Research

Save billions or stick with Humira? Drug brokers steer Americans to the costly choice

Does a high-dose influenza vaccine reduce cardiovascular disease risk?

First real-world observational study of the JADA®System, a medical device to control postpartum hemorrhage (PPH), published in ACOG’s Obstetrics & Gynecology

New treatment approach effectively treats the most aggressive forms of prostate cancer

AR headset proven effective digital tool for improving posture in people with Parkinson’s disease

Nanoparticle gene delivery system shows promise for treating ARDS

New study debunks the myth that almonds are bad for weight loss

Stem cell therapy shows promise in treating COVID-19 complications

Adaptive platform trial shows promise for finding new glioblastoma therapies

New study suggests higher buprenorphine doses could help save lives

Cancer drug could play a role in limiting the damaging effects of lung disease in COVID-19 patients

Health workers warn loosening mask advice in hospitals would harm patients and providers

Low socioeconomic status can negatively impact children's health starting in preschool, study finds

AI in clinical practice: positive outcomes dominate but questions linger, study finds

NIH launches Phase 1 trial of new investigational universal influenza vaccine

Purdue researcher receives $1.38 million to fight against drug-resistant malaria in developing countries

Oto and Lindus Health launch a remote trial to increase patient access to tinnitus therapy

Nuvectis launches Phase 1a dose escalation clinical trial of new cancer drug

N-acetylglucosamine reduces multiple inflammation and neurodegeneration markers in MS patients

New intrauterine device is highly effective in managing postpartum bleeding

Event guide: 15th World Clinical Biomarkers & CDx Europe eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer